)
Design Therapeutics (DSGN) investor relations material
Design Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Voting matters and shareholder proposals
Election of one Class II director nominee, Simeon George, M.D., for a three-year term ending at the 2029 annual meeting.
Ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Board of directors and corporate governance
Board recommends voting FOR both the director nominee and the auditor ratification proposals.
Audit committee and external auditor matters
Audit Committee selected Ernst & Young LLP as the independent auditor for the upcoming fiscal year.
- Virtual meeting to elect a director and ratify auditor, with focus on governance and compensation.DSGN
Proxy filing23 Apr 2026 - RESTORE-FA and pipeline programs advance toward key data, with funding secured into 2029.DSGN
Leerink Global Healthcare Conference 202610 Mar 2026 - GeneTACⓇ platform advances four programs for genetic diseases, with strong clinical and financial momentum.DSGN
Corporate presentation9 Mar 2026 - Clinical pipeline advanced, net loss $69.8M, cash reserves $219.8M fund operations into 2029.DSGN
Q4 20259 Mar 2026 - Clinical-stage genetic medicine programs in FA, FECD, and DM1 advance toward key data readouts.DSGN
Oppenheimer 36th Annual Healthcare Life Sciences Conference25 Feb 2026 - Lead programs use small molecules to restore or repress gene expression in major genetic diseases.DSGN
2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026 - Advancing four genomic medicine programs with clinical trials and strong financial runway.DSGN
Jefferies London Healthcare Conference 202413 Jan 2026 - Key clinical programs in FA and Fuchs advance toward pivotal 2025 milestones and data readouts.DSGN
Piper Sandler 36th Annual Healthcare Conference12 Jan 2026 - GeneTACⓇ platform advances four programs for severe genetic diseases with strong clinical momentum.DSGN
Corporate Presentation5 Jan 2026
Next Design Therapeutics earnings date
Next Design Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage